Jack Henkin

6.1k citations
111 papers · 4.8k indexed · h-index 42

Jack Henkin

111 papers receiving 4.7k citations

Peers

Jack Henkin
Comparison fields: 5 of 125
  • Cancer Research 2.1k
  • Immunology and Allergy 485
  • Hematology 881
  • Oncology 1.3k
  • Molecular Biology 2.5k
Replace Catherine Butterfield with:
Catherine Butterfield United States
George P. Tuszynski United States
Shafaat A. Rabbani Canada
Mario Del Rosso Italy
Brunhilde Felding‐Habermann United States
Walter E. Laug United States
Bruce A. Keyt United States
Shijie Sheng United States
Maria Vittoria Cubellis Italy
Giulia Taraboletti Italy
Jack Henkin relative to Catherine Butterfield United States Catherine Butterfield's profile →
Citations per field
00.5×1.7×
Catherine Butterfield · 1×
Citations per year

Countries citing papers authored by Jack Henkin

Since Specialization
Citations

This map shows the geographic impact of Jack Henkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Henkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Henkin more than expected).

Fields of papers citing papers by Jack Henkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Henkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Henkin. The network helps show where Jack Henkin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jack Henkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jack Henkin Line = papers co-authored together Jack Henkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20243
3 20236
4 20214
5 200940
6 200770
7 200620
8 200641
9 2005270
10 200043
11 1999139
12 1999116
13 199786
14 199475
15 199441
16 19921
17 19918
18 199163
19 198826
20 19887

About Jack Henkin

Jack Henkin is a scholar working on Cancer Research, Hematology and Biotechnology, having authored 111 papers that have together received 4.8k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (49 papers), Blood Coagulation and Thrombosis Mechanisms (24 papers), Peptidase Inhibition and Analysis (24 papers), Angiogenesis and VEGF in Cancer (21 papers), Enzyme Production and Characterization (11 papers), Signaling Pathways in Disease (7 papers), Cell Adhesion Molecules Research (7 papers) and Neuropeptides and Animal Physiology (5 papers). The work is most often cited by research in Cancer Research (2.1k citations), Immunology and Allergy (485 citations) and Hematology (881 citations). Jack Henkin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Andrew P. Mazar, Shafaat A. Rabbani, Jieyi Wang, Olga V. Volpert, Pingping Lou, Rick Lesniewski, David Goltzman, Donald J. Davidson, Andrew J. Schneider and Dudley K. Strickland. Their work appears in journals such as Journal of Biological Chemistry, Thrombosis Research, Biochemistry, Thrombosis and Haemostasis and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026